Novavax is on StockTwits radar as the flu vaccine company signs a deal with Spain’s health ministry to license technology and build infrastructure. Trading well above the upper Bollinger in an uptrend with a rising 20sma suggests that NVAX has more upside potential if it can stay above 2.25. This market can’t seem to get…